AI Nose Corporation
Update：2026/08/06
Industries
Main Industry
Health Care
Main Product/Service
Ainos is transforming itself into a diversified medtech leader through three innovative business arms:
1. Pharmaceuticals – Leveraging more than 100 scientific and clinical data studies to establish the next generation of low—dose interferons solutions
1. Pharmaceuticals – Leveraging more than 100 scientific and clinical data studies to establish the next generation of low—dose interferons solutions
Founded Year
2016
Unified Business No.
45050736
Status
Active
Number of Employees
0
Total Paid-in
Capital
5,000,000 (NT$)
Location of Company
Taiwan
, New Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
The Medical Device Division and AI Nose technology is a large step toward unlocking the final piece of medical diagnostic digitization, smell. Volatile organic compounds (VOCs) within the human body can be digitally profile and provide a future blueprint for personalized medicine. We refer to the digital ID related to VOCs as “Smell ID”. Our AI algorithms are transforming these Smell IDs into a value-added diagnostics and health acumen.
By combining leading-edge MEMS semiconductor manufacturing processes with easy-to-use, in-vitro diagnostics, point-of-care testing (IVD-POCT) devices, Ainos can quickly disseminate around the world. Within a few short years, Ainos launched AI-powered IVD-POCT devices for rapid COVID-19 detection, ventilator associated pneumonia detection, non-invasive feminine health diagnostics, and more.
By combining leading-edge MEMS semiconductor manufacturing processes with easy-to-use, in-vitro diagnostics, point-of-care testing (IVD-POCT) devices, Ainos can quickly disseminate around the world. Within a few short years, Ainos launched AI-powered IVD-POCT devices for rapid COVID-19 detection, ventilator associated pneumonia detection, non-invasive feminine health diagnostics, and more.
